[HTML][HTML] Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - Springer
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects and …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - pubmed.ncbi.nlm.nih.gov
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
[PDF][PDF] Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects …
L Carstens, M Popp, C Keicher, R Hertrampf… - 2023 - repository.ubn.ru.nl
BACKGROUND: Anhedonia and other deficits in reward-and motivation-related processing
in psychiatric patients, including patients with major depressive disorder (MDD), represent a …
in psychiatric patients, including patients with major depressive disorder (MDD), represent a …
Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects and …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - search.proquest.com
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
[HTML][HTML] Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - ncbi.nlm.nih.gov
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
[HTML][HTML] Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects …
L Carstens, M Popp, C Keicher, R Hertrampf… - …, 2023 - trialsjournal.biomedcentral.com
Anhedonia and other deficits in reward-and motivation-related processing in psychiatric
patients, including patients with major depressive disorder (MDD), represent a high unmet …
patients, including patients with major depressive disorder (MDD), represent a high unmet …
Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects and …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - europepmc.org
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects and …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - go.gale.com
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
Effects of a single dose of amisulpride on functional brain changes during reward-and motivation-related processing using task-based fMRI in healthy subjects and …
L Carstens, M Popp, C Keicher, R Hertrampf… - Trials, 2023 - europepmc.org
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
[PDF][PDF] Luisa Carstens1, Margot Popp2, Christian Keicher3, Rita Hertrampf3, David Weigner1, Marvin S. Meiering1
G Luippold, SD Süssmuth, CF Beckmann… - 2023 - trialsjournal.biomedcentral.com
Background Anhedonia and other deficits in reward-and motivation-related processing in
psychiatric patients, including patients with major depressive disorder (MDD), represent a …
psychiatric patients, including patients with major depressive disorder (MDD), represent a …